TotalSeq™-C0908 anti-human TCR Vβ13.1 Antibody, TCR Vβ13.1, H131,BioLegend,362411

Additional reported applications (for the relevant formats of this clone) include: activation of TCR Vß13.1 expressing cells1.

Host

Mouse

Reactivity

Human

Application

PG -Quality tested

Platform ID

BAB976877984

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NameTotalSeq™-C0908 anti-human TCR Vβ13.1 Antibody, TCR Vβ13.1, H131
Cat. No.362411
HostMouse
RRIDAB_2820020 (BioLegend Cat. No. 362411)
IsotypeMouse IgG2b, κ
ReactivityHuman
ApplicationPG -Quality tested
ClonalityMonoclonal
Clone NumberH131
Concentration0.5 mg/mL
TargetTCR Vbeta13.1
ImmunogenMouse T cell hybridoma
PurityThe antibody was purified by chromatography and conjugated with TotalSeq™-C oligomer under optimal conditions.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and EDTA
StorageThe antibody solution should be stored undiluted between 2°C and 8°C.Do not freeze.
Regulatory StatusResearch Use Only

Scientific Background

TCR Vβ13.1 is a variant of the TCR β chain. The receptor is complexed with the TCR α chain and belongs to the immunoglobulin superfamily. It is expressed on a subset of T cells and some T cell clones. Variability in the β chain is generated by Vβ, Dβ, and Jβ gene rearrangement, while variability in the α chain is generated by Vα and Jα rearrangement. TCR Vβ13.1 has been shown to be related to antigen recognition and inflammation as well as diseases, such as HIV and multiple sclerosis.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.